Search by Drug Name or NDC
NDC 51672-1338-06 Flo-Pred 16.7 mg/5mL Details
Flo-Pred 16.7 mg/5mL
Flo-Pred is a ORAL SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Taro Pharmaceuticals U.S.A., Inc.. The primary component is PREDNISOLONE ACETATE.
MedlinePlus Drug Summary
Prednisolone is used alone or with other medications to treat the symptoms of low corticosteroid levels (lack of certain substances that are usually produced by the body and are needed for normal body functioning). Prednisolone is also used to treat certain conditions that affect the blood, skin, eyes, central nervous system, kidneys, lungs, stomach, and intestines. It is also used to treat allergic reactions; and certain types of arthritis; multiple sclerosis (a disease in which the nerves do not function properly); and to help prevent transplant rejection (attack of the transplanted organ by the body) in certain adults who have received a transplant. Prednisolone is also sometimes used to treat symptoms from certain types of cancer. Prednisolone is in a class of medications called corticosteroids. It works by reducing swelling and redness and by changing the way the immune system works.
Related Packages: 51672-1338-06Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Prednisolone
Product Information
| NDC | 51672-1338 |
|---|---|
| Product ID | 51672-1338_79fbfd7c-6b29-466c-8e65-015be1652aea |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Flo-Pred |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Prednisolone Acetate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SUSPENSION |
| Route | ORAL |
| Active Ingredient Strength | 16.7 |
| Active Ingredient Units | mg/5mL |
| Substance Name | PREDNISOLONE ACETATE |
| Labeler Name | Taro Pharmaceuticals U.S.A., Inc. |
| Pharmaceutical Class | Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA022067 |
| Listing Certified Through | 2023-12-31 |
Package
NDC 51672-1338-06 (51672133806)
| NDC Package Code | 51672-1338-6 |
|---|---|
| Billing NDC | 51672133806 |
| Package | 1 BOTTLE in 1 CARTON (51672-1338-6) / 65 mL in 1 BOTTLE |
| Marketing Start Date | 2008-01-17 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |